Aerie Pharmaceuticals Inc AERI:NASDAQ

RT Quote | NASDAQ | USD
Last | 06/23/21 EDT
17.49quote price arrow down-0.22 (-1.24%)
Volume
732,369
52 week range
9.01 - 21.30

...

Loading . . .
  • Open17.79
  • Day High18.02
  • Day Low17.25
  • Prev Close17.49
  • 52 Week High21.30
  • 52 Week High Date03/15/21
  • 52 Week Low9.01
  • 52 Week Low Date10/21/20

Key Stats

  • Market Cap820.11M
  • Shares Out46.89M
  • 10 Day Average Volume0.59M
  • Dividend-
  • Dividend Yield-
  • Beta0.71
  • YTD % Change29.46

KEY STATS

  • Open17.79
  • Day High18.02
  • Day Low17.25
  • Prev Close17.49
  • 52 Week High21.30
  • 52 Week High Date03/15/21
  • 52 Week Low9.01
  • 52 Week Low Date10/21/20
  • Market Cap820.11M
  • Shares Out46.89M
  • 10 Day Average Volume0.59M
  • Dividend-
  • Dividend Yield-
  • Beta0.71
  • YTD % Change29.46

RATIOS/PROFITABILITY

  • EPS (TTM)-3.83
  • P/E (TTM)-4.57
  • Fwd P/E (NTM)-7.56
  • EBITDA (MRQ)-139.695M
  • ROE (MRQ)-301.15%
  • Revenue (MRQ)85.77M
  • Gross Margin (MRQ)69.75%
  • Net Margin (MRQ)-205.13%
  • Debt To Equity (MRQ)-2,084.18%

EVENTS

  • Earnings Date08/04/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Aerie Pharmaceuticals Inc

There is no recent news for this security.

Profile

MORE
Aerie Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is engaged in the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. The Company's product candidates include Rhopressa (netarsudil ophthalmic solution) 0.02% (Rhopressa), and Roclatan (netarsudil/latanoprost ophthalmic solution) 0.02%/0.005% (Roclatan). The Company's product candidates are designed to lower...
Vicente Anido Jr.,Ph.D.
Chairman
Thomas Mitro
President
Richard Rubino CPA
Chief Financial Officer
John Larocca Esq.
General Counsel
Address
4301 Emperor Blvd Ste 400
Durham, NC
27703-7615
United States

Top Peers

SYMBOLLASTCHG%CHG
OMER
Omeros Corp
15.45-0.01-0.06%
CDXC
Chromadex Corp
8.94+0.06+0.68%
ATRS
Antares Pharma Inc
4.34-0.01-0.23%
FLXN
Flexion Therapeutics Inc
8.93+0.07+0.79%
TXMD
TherapeuticsMD Inc
1.20+0.01+0.84%